1. Home
  2. MLGO vs CRBP Comparison

MLGO vs CRBP Comparison

Compare MLGO & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLGO
  • CRBP
  • Stock Information
  • Founded
  • MLGO 2018
  • CRBP 2009
  • Country
  • MLGO China
  • CRBP United States
  • Employees
  • MLGO N/A
  • CRBP N/A
  • Industry
  • MLGO EDP Services
  • CRBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLGO Technology
  • CRBP Health Care
  • Exchange
  • MLGO Nasdaq
  • CRBP Nasdaq
  • Market Cap
  • MLGO 99.2M
  • CRBP 114.8M
  • IPO Year
  • MLGO N/A
  • CRBP N/A
  • Fundamental
  • Price
  • MLGO $8.58
  • CRBP $9.73
  • Analyst Decision
  • MLGO
  • CRBP Strong Buy
  • Analyst Count
  • MLGO 0
  • CRBP 10
  • Target Price
  • MLGO N/A
  • CRBP $53.22
  • AVG Volume (30 Days)
  • MLGO 355.3K
  • CRBP 99.6K
  • Earning Date
  • MLGO 09-18-2025
  • CRBP 08-05-2025
  • Dividend Yield
  • MLGO N/A
  • CRBP N/A
  • EPS Growth
  • MLGO N/A
  • CRBP N/A
  • EPS
  • MLGO 16.40
  • CRBP N/A
  • Revenue
  • MLGO $74,185,505.00
  • CRBP N/A
  • Revenue This Year
  • MLGO N/A
  • CRBP N/A
  • Revenue Next Year
  • MLGO N/A
  • CRBP $220.04
  • P/E Ratio
  • MLGO $0.53
  • CRBP N/A
  • Revenue Growth
  • MLGO N/A
  • CRBP N/A
  • 52 Week Low
  • MLGO $8.13
  • CRBP $4.64
  • 52 Week High
  • MLGO $972.00
  • CRBP $61.72
  • Technical
  • Relative Strength Index (RSI)
  • MLGO 36.51
  • CRBP 55.66
  • Support Level
  • MLGO $8.63
  • CRBP $9.29
  • Resistance Level
  • MLGO $9.46
  • CRBP $10.66
  • Average True Range (ATR)
  • MLGO 0.59
  • CRBP 0.58
  • MACD
  • MLGO 0.63
  • CRBP -0.01
  • Stochastic Oscillator
  • MLGO 31.31
  • CRBP 50.00

About MLGO MicroAlgo Inc.

MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: